Abridge, founded in 2018, is a healthcare technology startup bringing generative AI to the medical field. The platform integrates with electronic health records (EHRs) to help healthcare providers minimize time spent on administrative tasks, enabling a focus on patient care. By summarizing medical notes and conversations, Abridge targets healthcare providers seeking to streamline documentation. The company is headquartered in Pittsburgh, Pennsylvania.

Register for Details

For more details on financing and valuation for Abridge, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Learn more about Abridge

Forge green plus iconForge green minus icon

What is Abridge's IPO price?

The IPO price for Abridge will be known only if it becomes public. However, you may access the "Price At Last Round" and the "Implied EV" for publicly traded comparable companies with Forge Data.
Forge green plus iconForge green minus icon

Can you invest in Abridge?

Abridge is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell Abridge shares pre-IPO?

If you own Abridge pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is Abridge a publicly traded company?

Abridge is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Forge green plus iconForge green minus icon

What is Abridge's funding to date?

Abridge has raised $207.98MM to date.
Forge green plus iconForge green minus icon

When was Abridge founded?

Abridge was founded in 2018.

Who are Abridge's major investors?

Spark Capital
Bessemer Venture Partners
Union Square Ventures
Kaiser Permanente Ventures
UPMC Enterprises
CVS Health Ventures
KdT Ventures
Wittington Ventures
Whistler Capital Partners
Pillar VC
LifePoint Health
UC Investments
American College of Cardiology Foundation
IKS Health
SCAN Group
Mayo Clinic

Abridge funding rounds and last known valuation

Date Funding Round Funding Raised Price per Share Last Known Valuation

Series C

$150MM raised $XXX.XX $XXX.XX

Series B

$30MM raised $XXX.XX $XXX.XX

Series A-1

$12.5MM raised $XXX.XX $XXX.XX

Series A

$10.16MM raised $XXX.XX $XXX.XX

Series Seed

$5.32MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data
Updated on: Jun 21, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.